Outcome Measures in Asthma Management

  • Michael Schatz
Part of the Allergy Frontiers book series (ALLERGY, volume 4)

Asthma outcomes are important for clinical research and clinical practice. Asthma outcomes represent at least five unique domains: symptoms, quality of life, pulmonary function, inflammatory markers, and exacerbations. Patient-reported outcomes include symptoms, rescue bronchodilator use, functional measures, multidimensional questionnaires (measuring asthma-specific quality of life and control), patient satisfaction, and change in medication requirement. Pulmonary function outcomes include spirometry (including fixed airway obstruction), peak expiratory flow rate, and lung volumes. Markers of airway inflammation include tests of airway hyperresponsiveness (such as methacholine challenge), sputum eosinophilia, and exhaled nitric oxide. Asthma exacerbations include fatal exacerbations and those that require urgent medical care. Asthma outcomes may be assessed using clinical or administrative data. Economic asthma outcomes include total, direct, and indirect costs. This chapter reviews definitions, prevalence, measurement tools, predictors, and interrelationships of the above outcomes.


Forced Vital Capacity Asthma Control Allergy Clin Immunol Respir Crit Asthma Exacerbation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Juniper EF, Wisniewski ME, Cox FM, et al. (2004). Relationship between quality of life and clinical status in asthma: a factor analysis. Eur Respir J 23:287–291PubMedCrossRefGoogle Scholar
  2. 2.
    Schatz M, Mosen D, Apter AJ, et al. (2005). Relationships between quality of life, severity, and control measures in asthma: an evaluation using factor analysis. J Allergy Clin Immunol 115:1049PubMedCrossRefGoogle Scholar
  3. 3.
    Holt EW, Cook EF, Covar RA, Spahn J, Fuhlbrigge AL (2008). Identifying the components of asthma health status in children with mild to moderate asthma. J Allergy Clin Immunol 121:1175–1180PubMedCrossRefGoogle Scholar
  4. 4.
    Rodrigo GJ, Arcos JP, Nannini LJ, Neffen H, Broin MG, Contrera M, Pineyro L (2008). Reliability and factor analysis of the Spanish version of the Asthma Control Test. Ann Allergy Asthma Immunol 100:17–22PubMedGoogle Scholar
  5. 5.
    Zhang J, Yu C, Holgate ST, Reiss TF (2002).Variability and lack of predictive ability of asthma end-points in clinical trials. Eur Respir J 20:1102–1109PubMedCrossRefGoogle Scholar
  6. 6.
    Sharek PJ, Mayer ML, Loewy L, Robinson TN, Shames RS, Umetso DT, Bergman DA (2002). Agreement among measures of asthma status: a prospective study of low-income children with moderate to severe asthma. Pediatrics 110:797–804PubMedCrossRefGoogle Scholar
  7. 7.
    Moy ML, Drazen JM (2001). Determinants of clinical responses in asthma. Clin Exp Allergy Rev 1:229–234CrossRefGoogle Scholar
  8. 8.
    Boot CRL, Vercoulen JHMM, van der Gulden JWJ, Orbon KH, van den Hoogen H, Folgering HThM (2005). Sick leave in patients with obstructive lung disease is related to psychosocial and work variables rather than to FEV1. Respir Med 99:1022–1031PubMedCrossRefGoogle Scholar
  9. 9.
    Nathan RA, Sorkness Ca, Kosinski MA, et al. (2004). Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunol 113:59–65PubMedCrossRefGoogle Scholar
  10. 10.
    Moy ML, Israel E, Weiss St, Juniper EF, Dube L, Drazen JM (2001). Clinical predictors of health-related quality of life depend on asthma severity. Am J Respir Crit Care Med 163:924–929PubMedGoogle Scholar
  11. 11.
    National Asthma Education and Prevention Program Expert Panel Report 3 (2007): Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 120 (suppl):S93–S138Google Scholar
  12. 12.
    Vollmer WM, Markson LE, O'Connor E, et al. (2002). Association of asthma control with health care utilization. Am J Resp Crit Care Med 165:195–199PubMedGoogle Scholar
  13. 13.
    Fuhlbrigge AL, Guilbert T, Spahn J, Peden D, David K (2006). The influence of variation in type and pattern of symptoms on assessment in pediatric asthma. Pediatrics 118:619–625PubMedCrossRefGoogle Scholar
  14. 14.
    Fuhlbrigge AL, Adams RJ, Guilbert TW, Grant E, Lozano P, Janson SL, Martinez F, Weiss KB, Weiss ST (2002). The burden of asthma in the United States. Am J Respir Crit Care Med 166:1044–1049PubMedCrossRefGoogle Scholar
  15. 15.
    Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J (1997). Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 10: 646–651PubMedGoogle Scholar
  16. 16.
    Yoos HL, Kitzman H, McMullen A, Sidora K (2003). Symptom perception in childhood asthma: how accurate are children and their parents? J Asthma 40:27–39PubMedCrossRefGoogle Scholar
  17. 17.
    Halterman JS, McConnochie KM, Conn KM, et al. (2004). A potential pitfall in provider assessments of the quality of asthma control. Ambul Pediatr 3:102–105CrossRefGoogle Scholar
  18. 18.
    Guyatt GH, Juniper EF, Griffith LE, et al. (1997). Children and adult perceptions of childhood asthma. Pediatrics 99:165–168PubMedCrossRefGoogle Scholar
  19. 19.
    Schatz M, Camargo C (2003). The relationship of gender to asthma prevalence, healthcare utilization, and medications in a large managed care organization. Ann All Asthma Immunol 91:553Google Scholar
  20. 20.
    Schatz M, Zeiger RS, Vollmer WM, et al. (2006). Predictors of future long-term asthma control. J Allergy Clin Immunol 118:1048PubMedCrossRefGoogle Scholar
  21. 21.–05/asthma03–05.htm (last accessed 11–6–08)
  22. 22.
    Schmier JK, Manjunath R, Halpern MT, Jones ML, Thompson K, Diette GB (2007). The impact of inadequately controlled asthma in urban children on quality of life and productivity. Ann Allergy Asthma Immunol 98:245–251PubMedCrossRefGoogle Scholar
  23. 23.
    Lim KG, Patel AM, Naessens JM, Li JT, Volcheck GW, Wagie AE, Enders FB, Beebe TJ (2008). Flunking asthma? When HEDIS takes the ACT. Am J Manag Care 14:487–494PubMedGoogle Scholar
  24. 24.
    Chen H, Blanc PD, Hayden ML, Bleecker ER, Chawla A, Lee JH (2008). Assessing productivity loss and asthma impairment in severe or difficult-to-treat asthma. Val Health 11:231–239CrossRefGoogle Scholar
  25. 25.
    Federico MJ, Wamboldt FS, Carter R, et al. (2007). History of serious asthma exacerbations should be included in guidelines of asthma severity. J Allergy Clin Immunol 119:50–56PubMedCrossRefGoogle Scholar
  26. 26.
    Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK (1992). Evaluation if impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 47:76–83PubMedCrossRefGoogle Scholar
  27. 27.
  28. 28.
    Schatz M, Mosen D, Kosinski M, et al. (2007). Validation of the Asthma Impact Survey, a brief asthma-specific quality of life tool. Qual Life Res 16:345PubMedCrossRefGoogle Scholar
  29. 29.
    Laforest L, Pacheco Y, Bartsch P, Vincken W, Pietri G, Ernst P, Berard A, Van Ganse E (2005). Correlates of quality of life in patients with asthma. Ann Allergy Asthma Immunol 94:473–479PubMedGoogle Scholar
  30. 30.
    Leidy NK, Coughlin C (1998). Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample. Qual Life Res 7:127–134PubMedCrossRefGoogle Scholar
  31. 31.
    Osborne ML, Vollmer WM, Linton KL, Buist AS (1998). Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med 157:123–128PubMedGoogle Scholar
  32. 32.
    Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL (1999). The influence of demographic and socioeconomic factors on health-related quality of life in asthma. J Allergy Clin Immunol 103:72–78PubMedCrossRefGoogle Scholar
  33. 33.
    Sippel JM, Pedula KL, Vollmer WM, et al. (1999). Associations of smoking with hospital-based care and quality of life in patients with obstructive airway diseases. Chest 115: 691–696PubMedCrossRefGoogle Scholar
  34. 34.
    Eisner MD, Iribarren C (2007). The influence of cigarette smoking on adult asthma outcomes. Nic Tob Res 9:53–56CrossRefGoogle Scholar
  35. 35.
    Erickson SR, Munzenberger PJ, Plante MJ, Kirking MJ, Hurwitz ME, Vanuya RZ (2002). Influence of sociodemographics on the health-related quality of life of pediatric patients with asthma and their caregivers. J Asthma 39:107–117PubMedCrossRefGoogle Scholar
  36. 36.
    Archea C, Yen IH, Chen H, Eisner MD, Katz PP, Masharani U, Yelin EH, Earnest G, Blanc PD (2007). Negative life events and quality of life in adults with asthma. Thorax 62:139–146PubMedCrossRefGoogle Scholar
  37. 37.
    Lavoie KL, Bacon SL, Labrecque M, Cartier A, Ditto B (2006). Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 100:648–657PubMedCrossRefGoogle Scholar
  38. 38.
    Lavoie KL, Bacon SL, Barone S, Cartier A, Ditto B, Labrecque M (2006). What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? Chest 130:1039–1047PubMedCrossRefGoogle Scholar
  39. 39.
    Kullowatz A, Kanniess F, Dahme B, Magnussen H, Ritz T (2007). Association of depression and anxiety with health care use and quality of life in asthma patients. Respir Med 101:638044CrossRefGoogle Scholar
  40. 40.
    Bayliss MS, Espindle DM, Buchner D, Blaiss MS, Ware JA (2000). A new tool for monitoring asthma outcomes: the ITG Asthma Short Form. Qual Life Res 9:451–466PubMedCrossRefGoogle Scholar
  41. 41.
    Katz PP, Eisner MD, Henke J, Shiboski S, Yelin EH, Blanc PD (1999). The Marks Asthma quality of life questionnaire: further validation and examination of responsiveness to change. J Clin Epidemiol 52:667–675PubMedCrossRefGoogle Scholar
  42. 42.
    Siroux V, Boudier A, Anto JM, Cazzoletti L, Accordini S, Alonso J, Cerveri I, Corsico A, Gulsvik A, Jarvis D, de Marco R, Marcon A, Marques EA, Bugiani M, Janson C, Leynaert B, Pin I (2008). Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study. Allergy 63:547–554PubMedCrossRefGoogle Scholar
  43. 43.
    Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR (1999). Validation of a standardized version of the Asthma Quality of life Questionnaire. Chest 115:1265–1270PubMedCrossRefGoogle Scholar
  44. 44.
    Ehrs P-O. Nokela M, Stallberg B, Hjemdahl P, Jonsson EW (2006). Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting. Chest 129:925–932PubMedCrossRefGoogle Scholar
  45. 45.
    Zorc JJ, Pawlowski NA, Allen JL, Bryant-Stephens T, Winston M, Angsuco C, Shea JA (2006). Development and validation of an instrument to measure asthma symptom control in children. J Asthma 43:753–758PubMedCrossRefGoogle Scholar
  46. 46.
    Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR (1999). Development and validation of a questionnaire to measure asthma control. Eur Respir J 14:902–907PubMedCrossRefGoogle Scholar
  47. 47.
    Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JL, Sullivan SD (2007). Asthma control, severity and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 120:396–402PubMedCrossRefGoogle Scholar
  48. 48.
    Kwon H-S, Lee S-H, Yang M-S, Lee S-M, Kim S-H, Kim D-I, Sohn S-W, Park C-H, Park H-W, Kim S-S, Cho S-H, Min K-U, Kim Y-Y, Chang Y-S (2008). Correlation between the Korean version of the Asthma Control Test and health-related quality of life in adult asthmatics. J Korean Med Sci 23:621–627PubMedCrossRefGoogle Scholar
  49. 49.
    Okelo SO, Wu AW, Krishnan JA, Rand CS, Skinner EA, Diette GB (2004). Emotional quality-of-life and outcomes in adolescents with asthma. J Pediatr 145:523–529PubMedCrossRefGoogle Scholar
  50. 50.
    Katz PP, Yelin EH, Eisner MD, Earnest G, Blanc PD (2004). Performance of valued life activities reflected asthma-specific quality of life more than general physical function. J Clin Epidemiol 57: 259–267PubMedCrossRefGoogle Scholar
  51. 51.
    Schatz M, Mosen D, Apter AJ, et al. (2005). The relationship of validated psychometric tools to subsequent medical utilization for asthma. J Allergy Clin Immunol 115:564–570PubMedCrossRefGoogle Scholar
  52. 52.
    Eisner MD, Ackerson LM, Chi F, et al. (2002). Health-related quality of life and future health care utilization for asthma. Ann Allergy Asthma Immunol 89:46–55PubMedGoogle Scholar
  53. 53.
    Tierney WM, Roesner JF, Seshadri R, Lykens MG, et al. (2004). Assessing symptoms and peak expiratory flow rate as predictors of asthma exacerbations. J Gen Intern Med 19:237–242PubMedCrossRefGoogle Scholar
  54. 54.
    Magid DJ, Houry D, Ellis J, et al. (2004). Health-related quality of life predicts emergency department utilization for patients with asthma. Ann Emerg Med 43:551–557PubMedCrossRefGoogle Scholar
  55. 55.
    Porsbjerg C, Rasmussen L, Nolte H, Backer V (2007). Association of airway hyperrespon-siveness with reduced quality of life in patients with moderate to severe asthma. Ann Allergy Asthma Immunol 98:44–50PubMedCrossRefGoogle Scholar
  56. 56.
    Li JT, Oppenheimer J, Bernstein IL, Nicklas RA (2005). Attaining optimal asthma control: a practice parameter. J Allergy Clin Immunol 116:S3–11CrossRefGoogle Scholar
  57. 57.
    Global Initiative for Asthma “Global Strategy for Asthma Management and Prevention”, revised 2006 http://www.ginasthma.orgl1=2&l2=1&intId=60 (last accessed 5-24-07)
  58. 58.
    Bateman Ed, Boushey HA, Bousquet J, Busse WW, Clark TJH, Pauwels RA, Pedersen SE (2004). Can guideline-defined asthma control be achieved? Am J Respir Crit Care Med 170:836–844PubMedCrossRefGoogle Scholar
  59. 59.
    Sullivan SD, Rasouliyan L, Russi Pam Kamath T, Chipps BE (2007). Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy 62:126–133PubMedGoogle Scholar
  60. 60.
    Laforest L, Van Ganse E, Devouassoux G, Chretin S, Bauguil G, Pacheco Y, Chamba G. (2005). Quality of asthma care: results from a community pharmacy-based survey. Allergy 60:1505–1510PubMedCrossRefGoogle Scholar
  61. 61.
    Partridge MR, van der Molen T, Myrseth S-E, Busse WW (2006). Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 6:13PubMedCrossRefGoogle Scholar
  62. 62.
    Soriano JB, Rabe KF, Vermiere PA (2003). Predictors of poor asthma control in European adults. J Asthma 40:803–813PubMedCrossRefGoogle Scholar
  63. 63.
    Wijnhoven HAH, Kriegsman DMW, Hesselink AE, de Haan M, Stalman W (2004). Disease control in general practice patients with asthma. Prim Care Respir J 13:89–98PubMedCrossRefGoogle Scholar
  64. 64.
    Carlton BG, Lucas DO, ellis EF, Conboy-Ellis K, Shoheiber O, Stempel DA (2005). The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices. J Asthma 42:529–535PubMedGoogle Scholar
  65. 65.
    Boulet L-P, Phillips R, O'Byrne P, Becker A (2002). Evaluation of asthma control by physicians and patients: comparison with current guidelines. Can Respir J 9:417–423PubMedGoogle Scholar
  66. 66.
    Holt S, Kljakovic M, Reid J (2003). Asthma morbidity, control and treatment in New Zealand: results of the Patient Outcomes Management Survey (POMS), 2001. NZMJ 116:U436Google Scholar
  67. 67.
    Laforest L, Van Ganse E, Devouassoux G, Bousquet J, Chretin S, Bauguil G, Pacheco Y, Chamba G (2006). Influence of patients' characteristics and disease management on asthma control. J Allergy Clin Immunol 117:1404–1410PubMedCrossRefGoogle Scholar
  68. 68.
    Leuppi JD, Steurer-Stey C, Peter M, Chhajed PN, Wildhaber JH, Spertini F. Asthma control in Switzerland: a general practitioner based survey (2006). Curr Med Res Opin 22:2159–2166PubMedCrossRefGoogle Scholar
  69. 69.
    Peters SP, Jones CA, Hasselkorn T, Mink DR, Valacer DJ, Weiss ST (2007). Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol 119:1454–1461PubMedCrossRefGoogle Scholar
  70. 70.
    Cazzolett L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, Accordini S, Almar E, Bugiani M, Carolei A, Cerveri I, Duran-Tauleria E, Gislason D, Gulsvik A, Jogi R, Marinoni A, Martinez-Moratalla J, Vermiere P, de Marco R (2007). Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol 120:1360–1367CrossRefGoogle Scholar
  71. 71.
    van den Nieuwenhof L, Schermer T, Heins M, Grootens J, Eysink P, Bottema B, van Weel C, Bindels P (2008). Tracing uncontrolled asthma in family practice using a mailed asthma control questionnaire. Ann Fam Med 6 (Suppl 1):S16–22PubMedCrossRefGoogle Scholar
  72. 72.
    Chapman KR, Boulet LP, Rea RM, Franssen E (2008). Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J 31:229–231CrossRefGoogle Scholar
  73. 73.
    Wallenstein G V, Corranza-Rosenzweig J, Kosinski M, Blaisdell-Gross B, Gajria K, Jhingran P (2007). A psychometric comparison of three patient-based measures of asthma control. Curr Med Res Opin 23:369–377PubMedCrossRefGoogle Scholar
  74. 74.
    Khalili B, Boggs PB, Shi R, Bahna SL (2008). Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide. Ann Allergy Asthma Immunol 101:124–129PubMedCrossRefGoogle Scholar
  75. 75.
    Schatz M, Mosen D, Kosinski M, Volmer WM, Magid DJ, O'Connor E, Zeiger RS (2007). The relationship between asthma-specific quality of life and asthma control. J Asthma 44:391–395PubMedCrossRefGoogle Scholar
  76. 76.
    LeBlanc A, Robichaud P, Lacasse Y, Boulet L-P (2007). Quantification of asthma control: validation of the Asthma Control Scoring System. Allergy 2007; 62:120–125Google Scholar
  77. 77.
    Juniper EF, Bousquet J, Abetz L, Bateman ED (2006). Identifying “well-controlled” and “not well-controlled” asthma using the Asthma Control Questionnaire. Respir Med 100:616–621PubMedCrossRefGoogle Scholar
  78. 78.
    Juniper EF, Svensson K, Mork A-C, Stahl E (2005). Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 99:553–558PubMedCrossRefGoogle Scholar
  79. 79.
    Ducharme FM, Davis GM, Noya F, Rich H, Ernst P (2004). The Asthma Quiz for Kidz: a validated tool to appreciate the level of asthma control in children. Can Respir J 11:541–546PubMedGoogle Scholar
  80. 80.
    Spencer S, Mayer B, Bendell KL, Bateman ED (2007). Validation of a guideline-based composite outcome assessment tool for asthma control. Respir Res 8:26PubMedCrossRefGoogle Scholar
  81. 81.
    Schatz M, Zeiger Rs, Drane A, et al. (2007). Reliability and predictive validity of the Asthma Control Test administered by telephone calls using speech recognition technology. J Allergy Clin Immunol 119:336–343PubMedCrossRefGoogle Scholar
  82. 82.
    LeNoir M, Williamson A, Stanford RH, Stempel DA (2006). Assessment of asthma control in a general population of asthmatics. Curr Med Res Opin 22:17–22PubMedCrossRefGoogle Scholar
  83. 83.
    de Vries MP, van den Bemt L, Lince S, Muris JWM, Thoonen BPA, Van Schayck CP (2005). Factors associated with asthma control. J Asthma 42:659–665PubMedCrossRefGoogle Scholar
  84. 84.
    Schatz M, Mosen DM, Kosinsky M, Vollmer WM, Magid DJ, O'Connor E, Zeiger RS (2007). Predictors of asthma control in a random sample of asthmatic patients. J Asthma 44:341–345PubMedCrossRefGoogle Scholar
  85. 85.
    Starobin D, Bargutin M, Rosenberg I, Yarmolovsky A, Levi T, Fink G (2007). Asthma control and compliance in a cohort of adult asthmatics: first survey in Israel. IMAJ 9:358–360PubMedGoogle Scholar
  86. 86.
    Chauhuri R, McSharry C, McCoard A, Livingston E, Hothersall E, Spears M, Lafferty J, Thomson NC (2008). Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy 63:132–135Google Scholar
  87. 87.
    Mehuys E, Bortel LV, Annemans L, Remon JP, Van Tongelen I, Van Ganse E, Laforest L, Chamba G, Bruselle G (2006). Medication use and disease control of asthmatic patients in Flanders: a cross-sectional community pharmacy study. Respir Med 100:1407–1414PubMedCrossRefGoogle Scholar
  88. 88.
    Vollmer WM, Markson LE, O'Connor E, Sanocki LL, Fitterman L, Berger M, Buist S (1999). Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 160:1647–1652PubMedGoogle Scholar
  89. 89.
    Peters D, Chen C, Markson L, et al. (2006). Using an asthma control questionnaire and administrative data to predict health-care utilization. Chest 129:918–924PubMedCrossRefGoogle Scholar
  90. 90.
    Calfee CS, Kathz PP, Yelin EH, et al. (2006). The influence of perceived control of asthma on health outcomes. Chest 130:1312–1318PubMedCrossRefGoogle Scholar
  91. 91.
    Miller MKI, Lee JH, Miller DP, Wenzel SE (2007). Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 101: 481–489PubMedCrossRefGoogle Scholar
  92. 92.
    Herhavez I, Nagy GB, Gyurkovits K, Magyar P, Dobos K, Nagy L, Alemao E, Ben-Joseph R (2003). Cost, morbidity, and control of asthma in Hungary: the Hunair study. J Asthma 40:673–681CrossRefGoogle Scholar
  93. 93.
    Accordini S, Bugiani M, Arossa W, Gerzeli S, Marioni A, Olivieri M, Pirina P, Carrozzi L, Dallari R, Togni AD, de Marco R (2006). Poor control increases the economic cost of asthma. Int Arch Allergy Immunol 141:189–198PubMedCrossRefGoogle Scholar
  94. 94.
    Van Ganse E, Laforest L, Pietri G, Boissel JP, Gormand F, Ben-Joseph R, Ernst P (2002). Persistent asthma: disease control, resource utilization and direct costs. Eur Respir J 20:260–267PubMedCrossRefGoogle Scholar
  95. 95.
    Damberg CL, Raube K, Williams T, Shortell SM (2006). Paying for performance: implementing a statewide project in California. Q Manag Health Care 14:66–79Google Scholar
  96. 96.
    Huang I-C, Dominici F, Frangakis C, Diette GB, Damberg CL, Wu AW (2006). Is risk-adjustor selection more important than statistical approach for provider profiling? Asthma as an example. Med Decis Making 25:20–34CrossRefGoogle Scholar
  97. 97.
    Campbell JL, Kiebert GM, Partridge MR (2003). Development of the satisfaction with inhaled asthma treatment questionnaire. Eur Respir J 22:127–134PubMedCrossRefGoogle Scholar
  98. 98.
    Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Mediction (TSQM), using a national panel of chronic disease. Health Qual Life Outcomes 2:12PubMedCrossRefGoogle Scholar
  99. 99.
    Barnes N (2001). Outcome measures in asthma. Clin Exp Allergy Rev 1:261–263CrossRefGoogle Scholar
  100. 100.
    Hankinson JL, Odencrantz JR, Fedan KB (1999). Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 159:179–187PubMedGoogle Scholar
  101. 101.
    Hansen JE, Sun X-G, Wasserman K (2007). Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest 131:349–355PubMedCrossRefGoogle Scholar
  102. 102.
    Yurdakul AS, Dursun B, Canbakan S, Cakaloglu A, Capan N (2005). The assessment of validity of different diagnostic tools in asthma. J Asthma 42:843–846PubMedCrossRefGoogle Scholar
  103. 103.
    Covar RA, Spahn JD, Martin RJ, Silkoff PE, Sundstrom DA, Murphy J, Szefler SJ (2004). Safety and application of induced sputum analysis in childhood asthma. J Allergy Clin Imunol 114:575–582CrossRefGoogle Scholar
  104. 104.
    Covar RA, Spahn JD, Murphy JR, Szefler SJ (2004). Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 170:234–241PubMedCrossRefGoogle Scholar
  105. 105.
    Swanney MP, Beckert LE, Frampton CM, Wallace LA, Jensen RL, Crapo RO. Validity of the American Thoracic Society and other spirometric algorithms using FVC and forced expiratory volume at 6 s for predicting a reduced total lung capacity (2004). Chest 126:1861–1866PubMedCrossRefGoogle Scholar
  106. 106.
    Aburuz S, McElnay J, Gamble J, Millership J, Heaney L (2005). Relationship between lung function and asthma symptoms in patients with difficult to control asthma. J Asthma 42:859–864PubMedCrossRefGoogle Scholar
  107. 107.
    Teeter JG, Bleecker ER (1998). Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest 113:272–277PubMedCrossRefGoogle Scholar
  108. 108.
    Shingo S, Zhang J, Reiss TF (2001). Correlation of airway obstruction and patient-reported endpoints in clinical studies. Eur Respir J 17:220–224PubMedCrossRefGoogle Scholar
  109. 109.
    Stahl E (2000). Correlation between objective measures of airway caliber and clinical symptoms in asthma: a systematic review of clinical studies. Respir Med 94:735–741PubMedCrossRefGoogle Scholar
  110. 110.
    Stout JW, Visness CM, Enright P, Lamm C, Shapiro G, Gan VN, Adams III GK, Mitchell HE (2006). Classification of asthma severity in children: the contribution of pulmonary function testing. Arch Pediatr Adolesc Med 160:844–850PubMedCrossRefGoogle Scholar
  111. 111.
    Fuhlbrigge AL, Kitch BT, Paltiel AD, Kuntz KM, Neumann PJ, Dockery DW, Weiss ST (2001). FEV1 is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 107:61–67PubMedCrossRefGoogle Scholar
  112. 112.
    Fuhlbrigge AL, Weiss ST, Kuntz KM, Paltiel AD (2006). Forced expiratory volume in 1 second percentage improves the classification of asthma severity among children with asthma. Pediatrics 118:347–355CrossRefGoogle Scholar
  113. 113.
    Gelb AF, Taylor CF, Shinar CM, Gutierrez C, Zamel N (2006). Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 129:1492–1499PubMedCrossRefGoogle Scholar
  114. 114.
    Osborne ML, Pedula KL, O'Hollaren M, Ettinger KM, Stibolt T, Buist AS, Vollmer WM (2007). Assessing future need for acute care in adult asthmatics. The profile of asthma risk study: a prospective health maintenance organization-based study. Chest 132:1151–1161PubMedCrossRefGoogle Scholar
  115. 115.
    Panizza JA, James AL, Ryan G, de Klerk N, Finucane KE (2006). Mortality and airflow obstruction in asthma: a 17-year follow-up study. Int Med J 36:773–780CrossRefGoogle Scholar
  116. 116.
    van der Merwe L, de Klerk A, Kidd M, Bardin PG, van Schalkwyk EM (2006). Case-control study of severe life-threatening asthma (SLTA) in a developing community. Thorax 61:756–760PubMedCrossRefGoogle Scholar
  117. 117.
    Connolly CK, Mamun M, Alcock SM, Prescott RJ (1998). The Darlington and Northallerton prospective asthma study: best function predicts mortality during the first 10 years. Respir Med 92:1274–1280PubMedCrossRefGoogle Scholar
  118. 118.
    Sutherland ER, Martin RJ, Bowler RP, Zhang Y, Rex MD, Kraft M (2004). Physiologic correlates of distal lung inflammation in asthma. J Allergy Clin Immunol 2004; 113:1046–1050CrossRefGoogle Scholar
  119. 119.
    Marazzini L, Cavigioli G, Mastropasqua B, Pelucchi A (1989). FEV1 decline in asymptomatic young adults: relationship with some tests of small airways function. Eur Respir J 2:817–821PubMedGoogle Scholar
  120. 120.
    Smith AD, Cowan JO, Filsell S, McLachlab C, Monti-Sheehan G, Jackson P, Taylor DR (2004). Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 169:473–478PubMedCrossRefGoogle Scholar
  121. 121.
    Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID (2002). A comparison of the validity of different diagnostic tests in adults with asthma. Chest 121:1051–1057PubMedCrossRefGoogle Scholar
  122. 122.
    Lange P, Parner J, Vestbo J, Schnohr P, Jensen G (1998). A 15-year follow-up study of ven-tilatory function in adults with asthma. N Engl J Med 339:1194–1200.PubMedCrossRefGoogle Scholar
  123. 123.
    Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A (2003). Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:418–424PubMedCrossRefGoogle Scholar
  124. 124.
    Lazaar AL, Panettieri, Jr RA (2003). Is airway remodeling clinically relevant in asthma. Am J Med 115:652–659PubMedCrossRefGoogle Scholar
  125. 125.
    Maud T, Bel EH, Sterk PJ (2007). Asthma therapy and airway remodeling. J Allergy Clin Immunol 120:997–1009CrossRefGoogle Scholar
  126. 126.
    Rasmussen F, Taylor R, Flannery EM, Cowan JO, Greene JM, Herbison GP, Sears M (2002). Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/ vital capacity ratio. Am J Respir Crit Care Med 165:1480–1488PubMedCrossRefGoogle Scholar
  127. 127.
    Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes PJ, Robinson D, Chung KF (2004). Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 24:122–128PubMedCrossRefGoogle Scholar
  128. 128.
    Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE (2007). Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma. Insights from the TENOR study. Chest 132:1882–1889Google Scholar
  129. 129.
    Jang A-S, Lee J-H, Park SW, Park J-S, Kim D-J, Park C-S (2007). Risk factors related to fixed airway obstruction in patients with asthma after antiasthma treatment. Ann Allergy Asthma Immunol 99:408–412PubMedCrossRefGoogle Scholar
  130. 130.
    ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH (2001). Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 164:744–748PubMedGoogle Scholar
  131. 131.
    Bai TR, Vonk JM, Postma DS, Boezen HM (2007). Severe exacerbations predict excess lung function decline in asthma. Eur Respir J 30:452–456PubMedCrossRefGoogle Scholar
  132. 132.
    ten Brinke A, van Dissel JT, Sterk PJ, Zwinderman AH, Rabe KF, Bel EH (2001). Persistent airflow obstruction in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol 2001; 107:449–454CrossRefGoogle Scholar
  133. 133.
    Yilmaz S, Ekici A, Ekici M, Keles H (2006). High-resolution computed tomography findings in elderly patients with asthma. Eur J Radiol 59:238–243PubMedCrossRefGoogle Scholar
  134. 134.
    deMarco R, Marcon A, Jarvis D, Accordini S, Bugiani M, Cazzoletti L, Cerveri I, Corsico A, Gialason D, Gulsvik A, Jogi R, Martinez-Moratalla J, Pin I, Janson C (2007). Inhaled ster-oids are associated with reduced lung function decline in subjects with asthma with elevated total IgE. J Allergy Clin Immunol 119:611–617PubMedCrossRefGoogle Scholar
  135. 135.
    Lange P, Scharling H, Ulrik CS, Vestbo J (2006). Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 61:100–104PubMedCrossRefGoogle Scholar
  136. 136.
    Dijkstra A, Vonk JM, Jongepier H, Koppelman GH, Schouten JP, ten Hacken NHT, Timens W, Postma DS (2006). Lung function decline in asthma: association with inhaled corticoster-oids, smoking and sex. Thorax 61:105–110PubMedCrossRefGoogle Scholar
  137. 137.
    O'Byrne PM, Pedersen S, Busse WW, Tan WC, Chen Y-Z, Ohlsson SV, Ullman A, Lamm CJ, Pauwels RA (2006). Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 129:1478–1485PubMedCrossRefGoogle Scholar
  138. 138.
    Capraz F, Kunter E, Cermik H, Ilvan A, Pocan S (2007). The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics. Lung 185:89–96PubMedCrossRefGoogle Scholar
  139. 139.
    in ‘t Veen JCCM, Beekman AJ, Bel EH, Sterk PJ (2000). Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 161:1902–1906Google Scholar
  140. 140.
    Kraft M, Pak J, Martin RJ, et al. (2001). Distal lung function at night in nocturnal asthma. Am J Respir Crit Care Med 163:1551–1556PubMedGoogle Scholar
  141. 141.
    Kraft M, Cairns CB, Ellison MC, Pak J, Irvin C, Wenzel S (2006). Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest 130:1726–1732PubMedCrossRefGoogle Scholar
  142. 142.
    Tunon-de-Lara J-M, Laurent F, Giraud V, Perez T, Aguilaniu B, Meziane H, Basset-Merle A, Chanez P (2007). Air trapping in mild and moderate asthma: effect of inhaled corticoster-oids. J Allergy Clin Immunol 119:583–590PubMedCrossRefGoogle Scholar
  143. 143.
    Menzies D, Nair A, Lipworth BJ (2006). Non-invasive measurement of airway inflammation in asthma. J Asthma 43:407–415PubMedCrossRefGoogle Scholar
  144. 144.
    Ward C, Reid DW, Orsida BE, Feltis B, Ryan VA, Johns DP, et al. (2005). Interrelationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma: a systematic bronchoalveolar lavage and airway biopsy analysis. Clin Exp Allergy 35:1565–1571PubMedCrossRefGoogle Scholar
  145. 145.
    American Thoracic Society (2000). Guidelines for methacholine and exercise challenge testing — 1999. Am J Respir Crit Care Med 161:309–329Google Scholar
  146. 146.
    Ward C, Pais M, Bish R, et al. (2002). Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002; 57:309–316CrossRefGoogle Scholar
  147. 147.
    Pizzichini E, Pizzichini MMM, Efthimiadis A, Dolovich J, Hargreave FE (1997). Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 99:539–544PubMedCrossRefGoogle Scholar
  148. 148.
    Sont JK, Willems LNA, Bel EH, van Krieken JHJM, Vandenbroucke JP, Sterk PJ (1999). Clinical control and histopathologic outcome of asthma when using airway hyperre-sponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 159:1043–1051PubMedGoogle Scholar
  149. 149.
    Van Den Berge M, Kerdstjens HAM, Meijer RJ, De Reuss DM, Koeter GH, Kauffman HF, Postma DS (2001). Corticosteroid-induced improvement in the PC20 of adenosine mono-phosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med 164:1127–1132PubMedGoogle Scholar
  150. 150.
    Porsbjerg C, Brannan JD, Anderson SD, Backer V (2008). Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthmatic patients. Clin Exper Allergy 38: 43–50Google Scholar
  151. 151.
    Lueppi JD, Salome CM, Jenkins CR, Anderson SD, Xuan W, Marks GB, et al. (2001). Predictive markers of asthma exacerbations during stepwise dose reduction of inhaled cor-ticosteroids. Am J Respir Crit Care Med 163:406–412Google Scholar
  152. 152.
    Pizzichini E, Pizzichini MMM, Efthimiadis A, Evans S, Morris Mm, Squillace D, Gleich GJ, Dolovich J, Hargreave FE (1996). Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 154:308–317PubMedGoogle Scholar
  153. 153.
    Deykin A (2006). Biomarker-driven care in asthma: are we there? J Allergy Clin Immunol 118:565–568PubMedCrossRefGoogle Scholar
  154. 154.
    Belda J, Parameswaran K, Lemiere C, Kamada D, O'Byrne PM, Hargreave FE (2006). Predictors of loss of asthma control induced by corticosteroid withdrawal. Can Respir J 13:129–133PubMedGoogle Scholar
  155. 155.
    Deykin A, Lazarus SC, Fahy J V, Wechsler ME, Boushey HA, Chinchilli VM, Craig TJ, Dimamgo E, Kraft M, Leone F, Lemanske RF, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Israel E (2005). Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol 115:720–727PubMedCrossRefGoogle Scholar
  156. 156.
    Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID (2002). Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 360:1715–1721PubMedCrossRefGoogle Scholar
  157. 157.
    Chlumsky J, Striz I, Terl M, Vondracek J (2006). Strategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthma. J Int Med Res 34:129–139PubMedGoogle Scholar
  158. 158.
    Jayaram L, Pizzichini MM, Cook RJ, Boulet L-P, Lemiere C, Pizzichini E, Cartier A, Goldsmith CH, Laviolette M, Parameswaran K, Hargreave FE (2006). Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 27:483–494PubMedCrossRefGoogle Scholar
  159. 159.
    Bates CA, Silkoff PE (2003). Exhaled nitric oxide in asthma: from bench to bedside. J Allergy Clin Immunol 111:256–262PubMedCrossRefGoogle Scholar
  160. 160.
    Zeidler M, Kleerup EC, Tashkin DP (2004). Exhaled nitric oxide in the assessment of asthma. Curr Opin Pulm Med 10:31–36PubMedCrossRefGoogle Scholar
  161. 161.
    Malmberg LP, Turpeinen H, Rytila P, Sarna S, Haahtela T (2005). Determinants of increased exhaled nitric oxide in patients with suspected asthma. Allergy 60:464–468PubMedCrossRefGoogle Scholar
  162. 162.
    Strunk RC, Szefler SJ, Phillips BR, Zeiger RS, Chinchilli VM, Larsen G, Hodgdon K, Morgan W, Sorkness CA, Lemanske, Jr RF (2003). Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 112:883–892PubMedCrossRefGoogle Scholar
  163. 163.
    Delgado-Corcoran C, Kissoon N, Murphy SP, Duckworth LJ (2004). Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med 5:48–52PubMedCrossRefGoogle Scholar
  164. 164.
    Meyts I, Proesmans M, De Boeck K (2003). Exhaled nitric oxide corresponds with office evaluation of asthma control. Ped Pulm 36:283–289CrossRefGoogle Scholar
  165. 165.
    Michils A, Baldassarre S, Van Muylem A (2008). Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J 31:539–546PubMedCrossRefGoogle Scholar
  166. 166.
    Jones SL, Herbison P, Cowan JO, et al. (2002). Exhaled NO and assessment of anti- inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 20:601–608PubMedCrossRefGoogle Scholar
  167. 167.
    Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, Khan M, Bush A (2005). Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 171:1077–1082PubMedCrossRefGoogle Scholar
  168. 168.
    Harkins MS, Fiato K-L, Iwamoto GK (2004). Exhaled nitric oxide predicts asthma exacerbations. J Asthma 41:471–476PubMedCrossRefGoogle Scholar
  169. 169.
    Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC (2005). Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 172:831–836PubMedCrossRefGoogle Scholar
  170. 170.
    Smith AD, Cowan JO, Brassett KP, Herbison P, Taylor DR (2005). Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352:2163–2173PubMedCrossRefGoogle Scholar
  171. 171.
    Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ, Pavord ID (2007). The use of exhaled nitric oxide to guide asthma management. A randomized controlled trial. Am J Respir Crit Care Med 176:231–237CrossRefGoogle Scholar
  172. 172.
    Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu AH, Wildfire JJ, Curry MD, Busse WW (2008). Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomized controlled trial. Lancet 372:1065–1072PubMedCrossRefGoogle Scholar
  173. 173.
    Sears MR (2008). Epidemiology of asthma exacerbations. J Allergy Clin Immunol 122: 662–668PubMedCrossRefGoogle Scholar
  174. 174.
    Getahun D, Demissie K, Rhoads GG (2005). Recent trends in asthma hospitalizations and mortality in the United States. J Asthma 42:373–378PubMedCrossRefGoogle Scholar
  175. 175.
    Sly RM (2004). Continuing decreases in asthma mortality in the United States. Ann Allergy Asthma Immunol 92:313–318PubMedCrossRefGoogle Scholar
  176. 176.
    Krishnan V, Diette GD, Rand CS, Bilderback AL, Merriman B, Hansel NN, Krishnan JA (2006). Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med 174:633–638PubMedCrossRefGoogle Scholar
  177. 177.
    Suissa S, Ernst P, Benayoun S, et al. (2000). Low-dose inhaled corticosteroids and the risk of death from asthma. N Engl J Med 343:332–336PubMedCrossRefGoogle Scholar
  178. 178.
    Abramson MJ, Bailey MJ, Couper FJ, Driver JS, Drummer OH, Forbes AB, McNeil JJ, Walters EH (2001). Are asthma medications and management related to deaths from asthma. Am J Respir Crit Care Med 163:12–18PubMedGoogle Scholar
  179. 179.
    Barton CA, Mckenzie DP, Walters EH, Abramson MJ. (2005). Interactions between psychosocial problems and management of asthma: who is at risk of dying? J Asthma 42:249–526PubMedCrossRefGoogle Scholar
  180. 180.
    Anderson HR, Ayres JG, Sturdy PM, Bland JM, Butland BK, Peckitt C, Taylor JC, Victor CR (2005). Bronchodilator treatment and deaths from asthma: case-control study. BMJ 330:117PubMedCrossRefGoogle Scholar
  181. 181.
    Hansen CJ, Russell KL, Smith TC, Neville JS, Krauss MR, Ryan MAK (2007). Asthma hospi-talizations among US military personnel, 1994–2004. Ann Allergy Asthma Immunol 98:36–43PubMedCrossRefGoogle Scholar
  182. 182.
    Leone FT, Grana JR, McDermott P, et al. (1999). Pharmaceutically-based severity stratification of an asthmatic population. Respir Med 93:788–793PubMedCrossRefGoogle Scholar
  183. 183.
    Lieu TA, Quesenberry CP, Sorel ME, Mendoza GR, Leong AB (1998). Computer-based models to identify high-risk children with asthma. Am J Respir Crit Care Med 157:1173–1180PubMedGoogle Scholar
  184. 184.
    Lieu TA, Capra AM, Quesenberry CP, Mendoza GR, Mazar M (1999). Computer-based models to identify high-risk adults with asthma: is the glass half empty or half full? J Asthma 36:359–370PubMedCrossRefGoogle Scholar
  185. 185.
    Schatz M, Nakahiro R, Jones CH, et al. (2004). Asthma population management: development and validation of a practical 3-level risk stratification scheme. Am J Manag Care 10:25–32PubMedGoogle Scholar
  186. 186.
    Schatz M, Zeiger RS, Vollmer WM, et al. (2006). Development and validation of a medication intensity scale derived from computerized pharmacy data that predicts emergency hospital utilization for persistent asthma. Am J Manag Care 12:478–484PubMedGoogle Scholar
  187. 187.
    Schatz M, Zeiger RS, Vollmer WM, et al. (2006). Validation of a β-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol 117:995–1000PubMedCrossRefGoogle Scholar
  188. 188.
    National Committee for Quality Assurance. HEDIS 2002. Volume 2: technical Specifications, Washington, DC: National Committee for Quality Assurance, 2001Google Scholar
  189. 189.
    Cabana MD (2004). Asthma severity for children. Pediatrics 114:1049–1055PubMedCrossRefGoogle Scholar
  190. 190.
    Wakefield DB, Cloutier MM (2006). Modifications to HEDIS and CSTE algorithms improve case recognition of pediatric asthma. Ped Pulm 41:962–971CrossRefGoogle Scholar
  191. 191.
    Berger WE, Legoretta AP, Blaiss MS, et al. (2004). The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol 93:538–545PubMedCrossRefGoogle Scholar
  192. 192.
    Schatz M, Nakahiro R, Crawford W, et al. (2005). Asthma quality of care markers using administrative data. Chest 128:1968PubMedCrossRefGoogle Scholar
  193. 193.
    Schatz M, Zeiger RS, Vollmer WM, et al. (2006). The controller to total asthma medication ratio is associated with patient-centered as well as utilization outcomes. Chest 130:43–50PubMedCrossRefGoogle Scholar
  194. 194.
    Schatz M, Stempel D (2008). Asthma quality-of-care measure using administrative data: relationships to subsequent exacerbations in multiple databases. Ann Allergy Asthma Immunol 101:235–239PubMedCrossRefGoogle Scholar
  195. 195.
    Schatz M, Broder M, Chang E, O'Connor R, Luskin A, Solari PG (2009). Asthma quality-of-care measure using administrative data: identifying the optimal denominator. Ann Allergy Asthma Immunol 102:98–102PubMedCrossRefGoogle Scholar
  196. 196.
    Cleland J, Thomas M, Price D (2003). Pharmacoeconomics of asthma treatment. Expert Opin Pharmacother 4:311–318PubMedCrossRefGoogle Scholar
  197. 197.
    Cisternas MG, Blanc PD, Yen IH, Katz PP, Earnest G, Eisner MD, Shiboski S, Yelin EH (2003). A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 111:1212–1218PubMedCrossRefGoogle Scholar
  198. 198.
    Weiss KB, Sullivan SD (2001). The health economics of asthma and rhinitis. I Assessing the economic impact. J Allergy Clin Immunol 107:3–8Google Scholar
  199. 199.
    Birnbaum HG, Berger WE, Greenberg PE, Holland M, Auerbach R$, Atkins KM, Wanke LA (2002). Direct and indirect costs of asthma to an employer. J Allergy Clin Immunol 109:264–270PubMedCrossRefGoogle Scholar
  200. 200.
    Lozano P, Fishman P, VonKorff M, Hecht J (1997). Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization. Pediatrics 99:757–764PubMedCrossRefGoogle Scholar
  201. 201.
    Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G (2002). Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J 19:61–67PubMedCrossRefGoogle Scholar
  202. 202.
    Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J (1998). Costs of asthma according to degree of severity. Eur Respir J 12:1322–1326PubMedCrossRefGoogle Scholar
  203. 203.
    Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A (1998). Integrating patient preferences into health outcomes assessment: the Multiattribute Asthma Symptom Utility Index. Chest 114:998–1007PubMedCrossRefGoogle Scholar
  204. 204.
    Moy ML, Fuhlbrigge AL, Blumenschein K, Chapman RH, Zillich AJ, Kuntz KM, Paltiel AD, Kitch BT, Weiss ST, Neumann PJ (2004). Association between preference-based health-related quality of life and asthma severity. Ann Allergy Asthma Immunol 92:329–334PubMedCrossRefGoogle Scholar
  205. 205.
    Szende A, Svednsson K, Stahl E, Meszaros A, Berta GY (2004). Psychometric and utility-based measures of health status of asthmatic patients with different disease control level. Pharmacoeconomics 22:537–547PubMedCrossRefGoogle Scholar
  206. 206.
    Flood EM, De Cock E, Mork A-C, Revicki DA (2006). Evaluating preference weights for the Asthma Symptoms Utility Index (ASUI) across countries. Health Qual Life Outcomes 4:51PubMedCrossRefGoogle Scholar
  207. 207.
    Briggs AH, Bousquet J, Wallace MV, Busse WW, Clark TJH, Pedersen SE, Bateman ED (2006). Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy 61:531–536PubMedCrossRefGoogle Scholar
  208. 208.
    Zillich AJ, Blumenschein K, Johannesson M, Freeman P (2002). Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthma. Pharmacoeconomics 20:257–265PubMedCrossRefGoogle Scholar
  209. 209.
    Juniper EF, Guyatt GH, Cox FM, Ferrie DJ, King DR (1999). Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 5:35–46Google Scholar
  210. 210.
    Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M (1996). Measuring quality of life in children with asthma. Qual Life Res 5:35–46PubMedCrossRefGoogle Scholar
  211. 211.
    Juniper EF, Guyatt GH, Feeny DH, et al. (1996). Measuring quality of life in the parents of children with asthma. Qual Life Res 5:27–34PubMedCrossRefGoogle Scholar
  212. 212.
    Skinner EA, Diette GB, Algatt-Bergstrom PJ, Nguyen TTH, Clark RD, Markson LE, Wu AW (2004). The Asthma Therapy Assessment Questionnaire (ATAQ) for children and adolescents. Dis Manag 7:305–313PubMedCrossRefGoogle Scholar
  213. 213.
    Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Majunath R (2007). Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 119:817–825PubMedCrossRefGoogle Scholar
  214. 214.
    Serrano J, Plaza V, Sureda B, de Pablo J, Picado C, Bardagi S, Lamela J, Sanchis J (2006). Alexithymia: a relevant psychological variable in near-fatal asthma. Eur Respir J 28:296–302PubMedCrossRefGoogle Scholar
  215. 215.
    Grant EN, Lyttle CS, Weiss KB (2000). The relation of socioeconomic factors and racial/ ethnic differences in US asthma mortality. Am J Public Health 90:1923–1925PubMedCrossRefGoogle Scholar
  216. 216.
    Gupta RS, Carrion-Caririe V, Weiss KB (2006). The widening black/white gap in asthma hospitalizations and mortality. J Allergy Clin Immunol 117:351–358PubMedCrossRefGoogle Scholar
  217. 217.
    Teerlink CC, Hegewald MJ, Cannon-Albright LA (2007). A genealogical assessment of heritable predisposition to asthma mortality. Am J Respir Crit Care Med 176: 865–870PubMedCrossRefGoogle Scholar
  218. 218.
    Alvarez GG, Schulzer M, Jung D, FitzGerald JM (2005). A systematic review of risk factors associated with near-fatal and fatal asthma. Can Respir J 12:265–270PubMedGoogle Scholar
  219. 219.
    Harrison B, Stephenson P, Mohan G, Nasser S (2005). An ongoing Confidential Enquiry into asthma deaths in the Eastern Region of the UK 2001–2003. Prim Care Respir J 14:303–313PubMedCrossRefGoogle Scholar
  220. 220.
    O'Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O'Connell EJ, Ballard DJ, Sachs MI (1991). Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 324:359–363PubMedCrossRefGoogle Scholar
  221. 221.
    Nannini LJ, Zaietta GA, Guerrera AJ, Varela JA, Fernandez OM, Flores DM (2007). Breath-holding test in subjects with near-fatal asthma. A new index for dyspnea perception. Respir Med 101:246–253Google Scholar
  222. 222.
    Kikuchi Y, Okabe S, Tamura G, Hida W, Homma M, Shirato K, et al. (1994). Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 330:1329–1334PubMedCrossRefGoogle Scholar
  223. 223.
    Magadle R, Berar-Yanay N, Weiner P (2002). The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest 121:329–333PubMedCrossRefGoogle Scholar
  224. 224.
    Greenberger PA, Miller TP, Lifschultz B (1993). Circumstances surrounding deaths from asthma in Cook County (Chicago) Illinois. Allergy Proc 14:321–326PubMedCrossRefGoogle Scholar
  225. 225.
    Strunk RC, Mrazek DA (1986). Deaths from asthma in childhood: can they be predicted? NER Allergy Proc 7:454–461PubMedCrossRefGoogle Scholar
  226. 226.
    Gottlieb DJ, Beiser AS, O'Connor GT (1995). Poverty, race, and medication use are correlates of asthma hospitalization rates. Chest 108:28–35PubMedCrossRefGoogle Scholar
  227. 227.
    To T, Dick P, Feldman W, Hernandez R (1996). A cohort study on childhood asthma admissions and readmissions. Pediatrics 98:191–195PubMedGoogle Scholar
  228. 228.
    Sarpong SB, Karrison T (1997). Sensitization to indoor allergens and the risk of asthma hospitalization in children. Ann Allergy Asthma Immunol 79:455–459PubMedCrossRefGoogle Scholar
  229. 229.
    Murray MD, Stang P, Tierney WM (1997). Health care use by inner-city patients with asthma. J Clin Epidemiol 50:167–174PubMedCrossRefGoogle Scholar
  230. 230.
    Caudio L, Tulton L, Doucette J, Landriagan PJ (1999). Socioeconomic factors and asthma hospitalization rates in New York City. J Asthma 36:343–350CrossRefGoogle Scholar
  231. 231.
    Tough SC, Hessel PA, Green FHY, et al. (1999). Factors that influence emergency department visits for asthma. Can Respir J 6:429–435PubMedGoogle Scholar
  232. 232.
    Lin S, Fitzgerald E, Hwang S, Munsie JP, Stark A (1999). Asthma hospitalization rates and socioeconomic status in New York state (1987–1993). J Asthma 36:239–251PubMedCrossRefGoogle Scholar
  233. 233.
    Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. (2001). Impact of inhaled antiinflamma-tory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics 107:706–711PubMedCrossRefGoogle Scholar
  234. 234.
    Schatz M, Cook EF, Joshua A, Petitti D (2003). Risk factors for asthma hospitalizations in a managed care organization: development of a clinical prediction rule. Am J Manag Care 9:538–547PubMedGoogle Scholar
  235. 235.
    Maziak W, von Mutius E, Keil U, et al. (2004). Predictors of health care utilization of children with asthma in the community. Pediatr Allergy Immunol 15:166–171PubMedCrossRefGoogle Scholar
  236. 236.
    Skobeloff EM, Spivey WH, St. Clair SS, Schoffstall JM (1992). The influence of age and sex on asthma admissions. JAMA 268:3437–3440PubMedCrossRefGoogle Scholar
  237. 237.
    Joseph CLM, Havstad SL, Ownby DR, Johnson CC, Tilley BC (1998). Racial differences in emergency department use persist despite allergist visits and prescriptions filled for anti-inflammatory medications. J Allergy Clin Immunol 101:484–490PubMedCrossRefGoogle Scholar
  238. 238.
    Behren J, Kreutzer R, Smith D (1999). Asthma hospitalization trends in California, 1983–1996. J Asthma 36:575–582CrossRefGoogle Scholar
  239. 239.
    Rasmussen F, Taylor DR, Flannery EM, et al. (2002). Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study. J Allergy Clin Immunol 110:220–227PubMedCrossRefGoogle Scholar
  240. 240.
    Debley JS, Redding GJ, Critchlow CW (2004). Impact of adolescence and gender on asthma hospitalization: a population-based birth cohort study. Ped Pulm 38:443–450CrossRefGoogle Scholar
  241. 241.
    Awadh N, Chu S, Grunfeld A, Simpson K, FitzGerald JM (1996). Comparison of males and females presenting with acute asthma to the emergency department. Respir Med 90:485–489PubMedCrossRefGoogle Scholar
  242. 242.
    Prescott E, Lange P, Vestbo J (1997). Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Thorax 52:287–289PubMedGoogle Scholar
  243. 243.
    Legoretta AP, Christian-Herman J O'Connor RD, et al. (1998). Compliance with national asthma management guidelines and specialty care. Arch Intern Med 158:457–464CrossRefGoogle Scholar
  244. 244.
    Singh AK, Cydulka RK, Stahmer SA, Woodruff PG, Camargo CA (1999). Sex differences among adults presenting to the emergency department with acute asthma. Arch Intern Med 159:1237–1243PubMedCrossRefGoogle Scholar
  245. 245.
    Tinkelman DG, McClure DL, Lehr TL, Schwartz AL (2002). Relationships between self-reported asthma utilization and patient characteristics. J Asthma 39:729–736PubMedCrossRefGoogle Scholar
  246. 246.
    Diette GB, Krishnan JA, Dominic F, et al. (2002). Asthma in older patients: factors associated with hospitalization. Arch Int Med 162:1123–1132CrossRefGoogle Scholar
  247. 247.
    Yurk RA, Diette GB, Skinner EA, et al. (2004). Predicting patient-reported asthma outcomes for adults in managed care. Am J Manag Care 10:321–328PubMedGoogle Scholar
  248. 248.
    Miller MK, Lee JH, Blanc PD, et al. (2006). TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma. Eur Respir J 28:1145–1155PubMedCrossRefGoogle Scholar
  249. 249.
    De Palo VA, Mayo PH, Friedman P, Rosen MJ (1994). Demographic influences on asthma hospital admission rates in New York City. Chest 106:447–451PubMedCrossRefGoogle Scholar
  250. 250.
    Cassino C, Ito K, Bader I, et al. (1999). Cigarette smoking and ozone-associated emergency department use for asthma by adults in New York City. Am J Respir Crit Care Med 159:1773–1779PubMedGoogle Scholar
  251. 251.
    Miller JE (1999). The effects of race/ethnicity and income on early childhood asthma prevalence and health care use. Am J Public Health 90:428–430CrossRefGoogle Scholar
  252. 252.
    Castro M, Schechtman KB, Halstead J, Bloomberg G (2001). Risk factors for asthma morbidity and mortality in a large metropolitan city. J Asthma 38:625–635PubMedCrossRefGoogle Scholar
  253. 253.
    Shireman TI, Heaton PC, Gay WE, et al. (2002). Relationship between asthma drug therapy patterns and healthcare utilization. Ann Pharmacother 36:557–564PubMedCrossRefGoogle Scholar
  254. 254.
    Haselkorn T, Lee JH, Mink DR, Weiss ST (2008). Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 101:256–263PubMedCrossRefGoogle Scholar
  255. 255.
    Lieu TA, Quesenberry CP, Capra AM, et al. (1997). Outpatient management practices associated with reduced risk of pediatric asthma hospitalization and emergency department visits. Pediatrics 100:334–341PubMedCrossRefGoogle Scholar
  256. 256.
    Eisner MD, Katz PP, Yelin EH, Shiboski SC, Blanc PD (2001). Risk factors for hospitaliza-tion among adults with asthma: the influence of sociodemographic factors and asthma severity. Respir Res 2:53–60PubMedCrossRefGoogle Scholar
  257. 257.
    Grana J, Preston S, McDermott PD, Hanchak NA (1997). The use of administrative data to risk-stratify asthmatic patients. Am J Med Qual 12:113–119PubMedCrossRefGoogle Scholar
  258. 258.
    Finkelstein JA, Barton MB, Donahue JG, et al. (2000). Comparing asthma care for Medicaid and non-Medicaid children in a health maintenance organization. Arch Pediatr Adolesc Med 154:563–568PubMedGoogle Scholar
  259. 259.
    Amre DK, Infante-Rivard C, Gautrin D, Malo J-L (2002). Socioeconomic status and utilization of health care services among asthmatic children. J Asthma 39:625–631PubMedCrossRefGoogle Scholar
  260. 260.
    Mancuso CA, Rincon M (2006). Impact of health literacy on longitudinal asthma outcomes. J Gen Intern Med 21:813–817PubMedCrossRefGoogle Scholar
  261. 261.
    Gaspal AP, Morais-Almeida MA, Pires GC, et al. (2002). Risk factors for asthma admissions in children. Allergy Asthma Proc 23:295–301Google Scholar
  262. 262.
    Mohammed F, Bootoor S, Panday A, et al. (2006). Predictors of repeat visits to the emergency room by asthmatic children in primary care. J Natl Med Assoc 98:1278–1284PubMedGoogle Scholar
  263. 263.
    Wakefield M, Ruffin R, Campbell D, et al. (1997). A risk screening questionnaire for adult asthmatics to predict attendance at hospital emergency departments. Chest 112:1527–1533PubMedCrossRefGoogle Scholar
  264. 264.
    Rand CS, Butz AM, Kolodner K, et al. (1999). Emergency department visits by urban African American children with asthma. J Allergy Clin Immunol 105:83–90CrossRefGoogle Scholar
  265. 265.
    Bartlett SJ, Kolodner K, Butz AM, et al. (2001). Maternal depressive symptoms and emergency department use among inner-city children with asthma. Arch Pediatr Adolesc Med 155:347–353PubMedGoogle Scholar
  266. 266.
    Diette GB, Krishnan JA, Wolfenden LL, et al. (2004). Relationship of physician estimate of underlying asthma severity to asthma outcomes. Ann Allergy Asthma Immunol 93:546–552PubMedCrossRefGoogle Scholar
  267. 267.
    Antonicelli L, Bucca C, Neri M, et al. (2004). Asthma severity and medical resource utilization. Eur Respir J 23:723–729PubMedCrossRefGoogle Scholar
  268. 268.
    Cowie RL, Underwood MF, Revitt SG, Field SK (2001). Predicting emergency department utilization in adults with asthma: a cohort study. J Asthma 38:179–184PubMedCrossRefGoogle Scholar
  269. 269.
    Dalcin PTR, Piovesan DM, Kang S, et al. (2004). Factors associated with emergency department visits due to asthma. Braz J Med Biol Res 37:1331–1338PubMedCrossRefGoogle Scholar
  270. 270.
    Ng T-P, Lim T-K, Abishheganaden J, et al. (2006). Factors associated with acute health care use in a national adult asthma management program. Ann Allergy Asthma Immunol 97:784–793PubMedCrossRefGoogle Scholar
  271. 271.
    Magadel R, Berar-Yanay N, Weiner P (2002). The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest 121:329–333CrossRefGoogle Scholar
  272. 272.
    Miller MKI, Lee JH, Miller DP, Wenzel SE (2007). Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 101: 481–489PubMedCrossRefGoogle Scholar
  273. 273.
    Sullivan SD, Wenzel SE, Bresnahan BW, Zheng B, Lee JH, Pritchard M, Kamath TV, Weiss ST (2007). Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy 62:655–660PubMedCrossRefGoogle Scholar
  274. 274.
    Sharma HP, Matsui EC, Eggleston PA, Hansel NN, Curtin-Brosnan J, Diette GB (2007). Does current asthma control predict future health care use among Black preschool-aged inner-city children? Pediatrics 120:e1174–e1181PubMedCrossRefGoogle Scholar
  275. 275.
    Peters AT, Klemens JC, Haselkorn T, Weiss ST, Grammer LC, Lee JH, Chen H (2008). Insurance status and asthma-related health care utilization in patients with severe asthma. Ann Allergy Asthma Immunol 100:301–307PubMedCrossRefGoogle Scholar
  276. 276.
    Kwong KYC, Morphew T, Scott L, Guterman J, Jones CA (2008). Asthma control and future asthma-related morbidity in inner-city asthmatic children. Ann Allergy Asthma Immunol 101:144–152PubMedCrossRefGoogle Scholar
  277. 277.
    Price D, Zhang Q, Kocevart VS, et al. (2005). Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy 35:282–287PubMedCrossRefGoogle Scholar
  278. 278.
    Kocevar VS, Thomas III J, Jonsson L, et al. (2005). Association between allergic rhinitis and hospital resource use among asthmatic children in Norway. Allergy 60:338–342CrossRefGoogle Scholar
  279. 279.
    Bousquet J, Gaugris S, Kocevar S, et al. (2005). Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clin Exp Allergy 35:723–727PubMedCrossRefGoogle Scholar
  280. 280.
    Cowie RL, Revitt S, Underwood MF, Field SK (1997). The effect of a peak flow-based action plan in the prevention of exacerbations of asthma. Chest 112:1534–1538PubMedCrossRefGoogle Scholar
  281. 281.
    Adams RJ, Smith BJ, Ruffin RE (2000). Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 55:566–573PubMedCrossRefGoogle Scholar
  282. 282.
    Freund DA, Stein J, Hurley R, et al. (1989). Specialty differences in the treatment of asthma. J Allergy Clin Immunol 84:401–406PubMedCrossRefGoogle Scholar
  283. 283.
    Zeiger RS, Heller S, Mellon WH, et al. (1991). Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits. J Allergy Clin Immunol 87:1160–1168PubMedCrossRefGoogle Scholar
  284. 284.
    Mahr TA, Evans R (1993). Allergist influence on asthma care. Ann Allergy 71:115–120PubMedGoogle Scholar
  285. 285.
    Sperber K, Ibrahim H, Hoffman B, et al. (1995). Effectiveness of a specialized asthma clinic in reducing asthma morbidity in an inner-city minority population. J Asthma 32:335–343PubMedCrossRefGoogle Scholar
  286. 286.
    Vollmer WM, O'Hallaren M, Ettinger M, et al. (1997). Specialty differences in the management of asthma: a cross sectional assessment of allergists' patents and generalist's patents n a large HMO. Arch Intern Med 157:1201–1208PubMedCrossRefGoogle Scholar
  287. 287.
    Kelly CS, Morrow AL, Shults J, et al. (2000). Outcomes evaluation of a comprehensive intervention program for asthmatic children enrolled in Medicaid. Pediatrics 105:1029–1035PubMedCrossRefGoogle Scholar
  288. 288.
    Schatz M, Cook EF, Nakahiro R, Petitti D (2003). Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthma. J Allergy Clin Immunol 111:503–508PubMedCrossRefGoogle Scholar
  289. 289.
    Hopman WM, Garvey N, Olajos-Clow J, et al. (2004). Outcomes of asthma education: results of a multisite evaluation. Can Respir J 11:291–297PubMedGoogle Scholar
  290. 290.
    Li D, German D, Lulla S, Thomas RG, Wilson SR (1995). Prospective study of hospitaliza-tion for asthma: a preliminary risk factor model. Am J Respir Crit Care Med 151:647–655PubMedGoogle Scholar
  291. 291.
    O'Driscoll BR, Hopkinson LC, Denning DW (2005). Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med 5:4PubMedCrossRefGoogle Scholar
  292. 292.
    Murray CS, Poletti G, Kebadze T, et al. (2006). Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hosptial admissions in children. Thorax 61:376–382PubMedCrossRefGoogle Scholar
  293. 293.
    Wenzel SE, Balzar S, Ampleford E, et al. (2007). IL4Ra mutations are associated with asthma exacerbations and mast cell/IgE expression. Am J Respir Crit Care Med 175:570–576PubMedCrossRefGoogle Scholar
  294. 294.
    Crystal-Peters J, Neslusan C, Crown WH, Torres A (2002). Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 109:57–62PubMedCrossRefGoogle Scholar
  295. 295.
    Eisner MD, Boland M, Tolstykh I, Mendoza G, Iribarren C (2005). Intensive care unit admission for asthma: a marker for severe disease. J Asthma 42:315–323PubMedGoogle Scholar
  296. 296.
    Cree M, Bell NR, Johnson D, et al. (2006). Increased continuity of care associated with decreased hospital care and emergency department visits for patients with asthma. Dis Manag 9:63–71PubMedCrossRefGoogle Scholar
  297. 297.
    Donahue JG, Weiss ST, Livingston JM, et al. (1997). Inhaled steroids and the risk of hospi-talization for asthma. JAMA 277:887–891PubMedCrossRefGoogle Scholar
  298. 298.
    Anis AH, Lynd LD, Wang X-H, et al. (2001). Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 164:625–631PubMedGoogle Scholar
  299. 299.
    Senthilselvan A, Lawson JA, Rennie DC, et al. (2005). Regular use of corticosteroids and low use of short-acting β2-agonists can reduce asthma hospitalization. Chest 127:1242–1251PubMedCrossRefGoogle Scholar
  300. 300.
    Balkrishnan R, Christensen DB (2000). Inhaled corticosteroid nonadherence and immediate avoidable medical events in older adults with chronic pulmonary ailments. J Asthma 37:511–517PubMedCrossRefGoogle Scholar
  301. 301.
    Williams LK, Pladevall M, Hugo X, et al. (2004). Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 114:1288–1293PubMedCrossRefGoogle Scholar
  302. 302.
    Frisher M, Heatlie H, Chapman S, et al. (2000) Ratio of inhaled corticosteroid to bronchodi-lator treatment and asthma hospitalization. Curr Med Res Opin 16:8–13CrossRefGoogle Scholar
  303. 303.
    Fuhlbrigge A, Carey VJ, Adams RJ, et al. (2004). Evaluation of asthma prescription measures and health system performance based on emergency department utilization. Med Care 42:465–471PubMedCrossRefGoogle Scholar
  304. 304.
    Schatz M, Chen PT, Macy E, Zeiger RS (2005). Dispensing of proton pump inhibitor medication is independently associated with subsequent asthma emergency hospital utilization. Am J Med 118:431PubMedCrossRefGoogle Scholar
  305. 305.
    Balkrishnan R, Norwood GJ, Anderson A (1998). Outcomes and cost benefits associated with the introduction of inhaled corticosteroids in a Medicaid population of asthmatic patients. Clin Ther 20:567–580PubMedCrossRefGoogle Scholar
  306. 306.
    Blais L, Ernst P, Jean-Francois B, Suissa S (1998). Inhaled corticosteoids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 158:126–132PubMedGoogle Scholar
  307. 307.
    Blais L, Suissa S, Boivin J-F, Ernst P (1998). First treatment with inhaled steroids and the prevention of admission to hospital for asthma. Thorax 53:1025–1029PubMedCrossRefGoogle Scholar
  308. 308.
    Rowe BH, Bota GW, Fabris L, et al. (1999). Inhaled budesonide in addition to oral corti-costeroids to prevent asthma relapse following discharge from the emergency department. JAMA 281:2119–2126PubMedCrossRefGoogle Scholar
  309. 309.
    Suissa S, Ernst P, Kezouh A (2002). Regular use of inhaled corticosteroids and the long term prevention of hospitalization for asthma. Thorax 57:880–884.PubMedCrossRefGoogle Scholar
  310. 310.
    Sin DD, Man SF (2002). Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Int Med 162:1591–1595CrossRefGoogle Scholar
  311. 311.
    Smith MJ, Rascati KL, McWilliams BC (2004). Inhaled ant-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program. Ann Allergy Asthma Immunol 92:40–46PubMedCrossRefGoogle Scholar
  312. 312.
    Silverman RA, Nowak RM, Korenblat PE, et al. (2004). Zafirlukast treatment for acute asthma. Chest 126:1480–1489PubMedCrossRefGoogle Scholar
  313. 313.
    Johnston NW, Johnston SL, Duncan JM, et al. (2005). The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 115:132–138PubMedCrossRefGoogle Scholar
  314. 314.
    Corren J, Casale T, Deniz Y, Ashby M (2003). Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalization in patients with allergic asthma. J Allergy Clin Immunol 111:87–90PubMedCrossRefGoogle Scholar
  315. 315.
    Bousquet J, Cabrera P, Berkman N, et al. (2005). The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 60:302–308PubMedCrossRefGoogle Scholar
  316. 316.
    Humbert M, Beasley R, Ayres J, et al. (2005). Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 60:309–316PubMedCrossRefGoogle Scholar
  317. 317.
    Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST (2002). Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 109:636–642PubMedCrossRefGoogle Scholar
  318. 318.
    Corren J, Manning BE, Thompson SF, et al. (2004). Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol 113:415–419PubMedCrossRefGoogle Scholar
  319. 319.
    Eisner MD, Klein J, Hammond SK, et al. (2005). Directly measured second hand smoke exposure and asthma health outcomes. Thorax 60:814–821PubMedCrossRefGoogle Scholar
  320. 320.
    Lemiere C, Forget A, Dufour M-H, Boulet L-P, Blais L (2007). Characteristics and medical resource use of asthmatic subjects with and without work-related asthma. J Allergy Clin Immunol 120:1354–1359PubMedCrossRefGoogle Scholar
  321. 321.
    Brown ES, Gan V, Jeffress J, et al. (2006). Psychiatric symptomatology and disorders in caregivers of children with asthma. Pediatrics 118:1715–1720CrossRefGoogle Scholar
  322. 322.
    TenBrinke A, Ouwerkerk ME, Zwindeman AH, Spinhover P, Bel EH (2001). Psychopathology in patents seen with severe asthma is associated with increased health care utilization. Am J Respir Crit Care Med 1093–1096Google Scholar
  323. 323.
    Eisner MD, Katz PP, Lactao G, et al. (2005). Impact of depressive symptoms on adult asthma outcomes. Ann Allergy Asthma Immunol 94:566–574PubMedCrossRefGoogle Scholar
  324. 324.
    Wainwright NWJ, Surtees PG, Wareham NJ, Harrison BDW (2007). Psychosocial factors and incident asthma hospital admissions in the EPIC-Norfolk cohort study. Allergy 62:554–560PubMedCrossRefGoogle Scholar
  325. 325.
    Baptist AP, Warrier I, Arora R, et al. (2007). Hospitalized patients with asthma who leave against medical advice: characteristics, reasons, and outcomes. J Allergy Clin Immunol 119:924–929PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Michael Schatz
    • 1
  1. 1.Department of AllergyKaiser Permanente Medical CenterSan DiegoUSA

Personalised recommendations